Synthesis, characterization and DFT calculations of linear and NLO properties of novel (Z)-5-benzylidene-3-N(4-methylphenyl)-2-thioxothiazolidin-4-one

被引:24
|
作者
Bensafi, T. [1 ]
Hadji, D. [2 ]
Yahiaoui, A. [1 ]
Argoub, K. [1 ]
Hachemaoui, A. [1 ]
Kenane, A. [1 ]
Baroudi, B. [1 ]
Toubal, K. [3 ]
Djafri, A. [3 ]
Benkouider, A. M. [1 ]
机构
[1] Univ Mascara, Fac Exact Sci, Lab Organ Chem Macromol & Mat, Mascara, Algeria
[2] Univ Saida Dr Moulay Tahar, Modelling & Calculat Methods Lab, Saida 20000, Algeria
[3] Univ Oran 1 Ahmed Ben Bella, Fac Sci, Dept Chem, Lab Appl Organ Synth, Oran, Algeria
关键词
Thiazolidinone; spectroscopy; NLO; hyper-Rayleigh scattering; DFT; NONLINEAR-OPTICAL PROPERTIES; DENSITY-FUNCTIONAL THEORY; MILD-STEEL; RHODANINE DERIVATIVES; BIOLOGICAL EVALUATION; CORROSION INHIBITION; BAND-GAP; ACID; ADSORPTION; DISCOVERY;
D O I
10.1080/17415993.2021.1951729
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
In the present investigation, we report a combined experimental and theoretical study of (Z)-5-benzylidene-3-N(4-methylphenyl)-2-thioxothiazolidin-4-one synthesized by the Knoevenagel condensation of rhodanine with an aromatic aldehyde in good to excellent yields. A variety of physicochemical techniques were employed for characterization of the synthesized compound including H-1 and C-13 nuclear magnetic resonance (NMR), scanning electron microscopy (SEM), energy dispersive X-Ray analysis (EDX) and ultraviolet-visible (UV-VIS) spectroscopy. The geometry optimization, frontier molecular orbital energies and the energy gap of the title compound in the ground state have been investigated with density functional theory (DFT) method at different functionals (B3LYP, CAM-B3LYP, M05-2X, PBE0, and omega B97X-D) in conjunction with different basis sets. We also calculate their dipole moment, linear polarizability, and first hyperpolarizability to elucidate the nonlinear optical (NLO) activity. The HOMO-LUMO energy gap obtained from the PBE0 functional agrees with the experimental data deduced from the UV-VIS measurement. The resulting compound shows a high hyper-Rayleigh scattering (HRS) first hyperpolarizability, which makes it suitable for optoelectronic and optical devices.
引用
收藏
页码:645 / 663
页数:19
相关论文
共 50 条
  • [31] Synthesis and evaluation of the antimicrobial activities of 3-((5-phenyl-1,3,4-oxadiazol-2-yl)methyl)-2-thioxothiazolidin-4-one derivatives
    Liu, Jia-Chun
    Zheng, Chang-Ji
    Wang, Meng-Xiao
    Li, Ya-Ru
    Ma, Long-Xu
    Hou, Shao-Pu
    Piao, Hu-Ri
    EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2014, 74 : 405 - 410
  • [32] In Silico Studies of (Z)-3-(2-Chloro-4-Nitrophenyl)-5-(4-Nitrobenzylidene)-2-Thioxothiazolidin-4-One Derivatives as PPAR-γ Agonist: Design, Molecular Docking, MM-GBSA Assay, Toxicity Predictions, DFT Calculations and MD Simulation Studies
    Srinivasa, Mahendra Gowdru
    Shivakumar, D.
    Kumar, D. Udaya
    Mehta, Chetan Hasmukh
    Nayak, Usha Yogendra
    Revanasiddappa, B. C.
    JOURNAL OF COMPUTATIONAL BIOPHYSICS AND CHEMISTRY, 2024, 23 (01): : 117 - 136
  • [33] Synthesis and characterization of 3-acetoxy-2-methyl-N-(phenyl) benzamide and 3-acetoxy-2-methyl-N-(4-methylphenyl)benzamide
    Kirca, Basak Kosar
    Cakmak, Sukriye
    Kutuk, Halil
    Odabasoglu, Mustafa
    Buyukgungor, Orhan
    JOURNAL OF MOLECULAR STRUCTURE, 2018, 1151 : 191 - 197
  • [34] AFM and SEM Characterization of Chemically Modified Electrodes Based on 5-[(azulen-l-yl) methylene]-2-thioxothiazolidin-4-one
    Pop, Maria Daniela
    Brincoveanu, Oana
    Cristea, Mihaela
    Buica, George Octavian
    Enachescu, Marius
    Ungureanu, Eleonora Mihaela
    REVISTA DE CHIMIE, 2017, 68 (12): : 2799 - 2803
  • [35] Efficacy, pharmacokinetics, tisssue distribution, and metabolism of the Myc–Max disruptor, 10058-F4 [Z,E]-5-[4-ethylbenzylidine]-2-thioxothiazolidin-4-one, in mice
    Jianxia Guo
    Robert A. Parise
    Erin Joseph
    Merrill J. Egorin
    John S. Lazo
    Edward V. Prochownik
    Julie L. Eiseman
    Cancer Chemotherapy and Pharmacology, 2009, 63 : 615 - 625
  • [36] Design and Synthesis of (Z)-5-(Substituted benzylidene)-3-cyclohexyl-2-thioxothiazolidin-4-one Analogues as Anti-Tyrosinase and Antioxidant Compounds: In Vitro and In Silico Insights
    Ko, Jeongin
    Lee, Jieun
    Jung, Hee Jin
    Ullah, Sultan
    Jeong, Yeongmu
    Hong, Sojeong
    Kang, Min Kyung
    Park, Yu Jung
    Hwang, YeJi
    Kang, Dongwan
    Park, Yujin
    Chun, Pusoon
    Yoo, Jin-Wook
    Chung, Hae Young
    Moon, Hyung Ryong
    ANTIOXIDANTS, 2022, 11 (10)
  • [37] Synthesis of N2-(substituted benzyl)-3-(4-methylphenyl)indazoles as novel anti-angiogenic agents
    Huang, LJ
    Shih, ML
    Chen, HS
    Pan, SL
    Teng, CM
    Lee, FY
    Kuo, SC
    BIOORGANIC & MEDICINAL CHEMISTRY, 2006, 14 (02) : 528 - 536
  • [38] One-Pot Synthesis of the 5-Benzylidene-2-thioxothiazolidin-4-one Derivative and Screening of Metal Catalysts Using Fruit Juice
    Binhydra, N. M.
    Sarkate, A. P.
    Wagh, M. S.
    Pawar, S. S.
    Kankal, P. K.
    Patwekar, G. V.
    Pund, A. A.
    Pansare, D. N.
    Shelke, R. N.
    Bhandari, S. V.
    RUSSIAN JOURNAL OF ORGANIC CHEMISTRY, 2024, 60 (07) : 1225 - 1232
  • [39] Design and synthesis of an N-benzyl 5-(4-sulfamoylbenzylidene-2-thioxothiazolidin-4-one scaffold as a novel NLRP3 inflammasome inhibitor
    Zuo, Dongxu
    Do, Nayeon
    Hwang, Inhwa
    Ann, Jihyae
    Yu, Je-Wook
    Lee, Jeewoo
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2022, 65
  • [40] Efficacy, pharmacokinetics, tisssue distribution, and metabolism of the Myc-Max disruptor, 10058-F4 [Z,E]-5-[4-ethylbenzylidine]-2-thioxothiazolidin-4-one, in mice
    Guo, Jianxia
    Parise, Robert A.
    Joseph, Erin
    Egorin, Merrill J.
    Lazo, John S.
    Prochownik, Edward V.
    Eiseman, Julie L.
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2009, 63 (04) : 615 - 625